facebook linkedin twitter

Moderna Expanding Kids Vaccine Study to Better Assess Safety

July 27, 2021by Matthew Perrone and Linda A. Johnson, Associated Press
In this March 29, 2021 file photo, a worker readies syringes with the Moderna COVID-19 vaccine in Metairie, La. Moderna plans to expand the size of its study in younger children to better detect rare side effects. The company said Monday, July 26, 2021 it is in talks with the Food and Drug Administration to enroll more patients in its study of the vaccine in children under 12 years old and younger. (AP Photo/Gerald Herbert, File)

WASHINGTON (AP) — Moderna said Monday it plans to expand the size of its COVID-19 vaccine study in younger children to better detect rare side effects, such as a type of heart inflammation recently flagged by U.S. health authorities.

The company said it is in talks with the Food and Drug Administration to enroll more study participants under age 12. It had intended to test the vaccine in about 7,000 children, with some as young as 6 months. The Cambridge, Massachusetts-based company said via email it hasn’t decided on how many kids might be added. 

The announcement comes as U.S. COVID-19 cases are rising and schools prepare to welcome students back to classrooms. At the same time, regulators continue to review cases of a rare type of heart inflammation called myocarditis that has been reported in a small number of teenagers who got the Moderna or Pfizer shots.

Pfizer said on Monday that if it makes changes to its vaccine testing in children, it will provide an update then. The New York-based company is testing its vaccine in up to 4,500 children in the United States and Europe.

The FDA said in a statement it could not comment on its discussions with companies, but added “we do generally work with sponsors to ensure the number of participants in clinical trials are of adequate size to detect safety signals.”

The news was first reported by the New York Times.

U.S. officials and independent medical experts said last month the benefits of the vaccines far outweigh the risks of the side effect, which has been reported in several hundred people younger than 30. But any vaccine safety issues could slow uptake, particularly among parents wary of taking any health risk with their children.

Currently, Pfizer has the only U.S. vaccine authorized for children 12 years and up, while Moderna is expecting an FDA ruling on its application in the coming days.

While teens receive the same dose as adults, younger children may need smaller doses. That additional complexity adds time to drugmakers’ research and application timelines.

Moderna said Monday it expects to have enough data to apply for FDA authorization in younger kids by late this year or early 2022. 

Pfizer has previously said it expects to apply in September for children ages 5 through 11. Results for two younger age groups that began testing a little later should be available by October or November, according to the company.

___

 Johnson reported from Fairless Hills, Pennsylvania.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Health

September 17, 2021
by Dan McCue
FDA Panel Backs COVID-19 Boosters Only for Elderly, Those at High-Risk

WASHINGTON - A Food and Drug Administration advisory panel voted unanimously Friday to recommend emergency use authorization of a booster... Read More

WASHINGTON - A Food and Drug Administration advisory panel voted unanimously Friday to recommend emergency use authorization of a booster dose of Pfizer-BioNTech COVID-19 vaccine six months after full vaccination in people 65 and older and those at high risk of severe Covid-19. But the same... Read More

September 15, 2021
by Reece Nations
CDC Interim Estimates Find Moderna Vaccines Most Effective Against Delta Breakthroughs

WASHINGTON — Data collected by the Centers for Disease Control and Prevention on COVID-19's delta variant found that vaccine efficacy... Read More

WASHINGTON — Data collected by the Centers for Disease Control and Prevention on COVID-19's delta variant found that vaccine efficacy was higher among recipients of the Moderna vaccination at 95%, higher than both the Pfizer-BioNTech and the Johnson & Johnson vaccines. The CDC collected data in... Read More

September 15, 2021
by Alexa Hornbeck
U.S. Health System Trails Far Behind Other High-income Countries

The COVID-19 pandemic has shown that no nation has the perfect health system, but a report from the Commonwealth Fund... Read More

The COVID-19 pandemic has shown that no nation has the perfect health system, but a report from the Commonwealth Fund finds the U.S. trails far behind other high-income countries on measures of health care affordability, administrative efficiency, equity, and outcomes. By analyzing 11 high-income countries and... Read More

September 15, 2021
by Alexa Hornbeck
Study: Getting Vaccinated Against COVID-19 Can Improve Mental Health

LOS ANGELES, Calif. -- A year-long study conducted by researchers from the University of Southern California finds that getting vaccinated... Read More

LOS ANGELES, Calif. -- A year-long study conducted by researchers from the University of Southern California finds that getting vaccinated against COVID-19 can actually improve mental health. “We were interested to see what the short-term effects of getting a COVID-19 vaccination would be on people’s mental... Read More

President, CEOs, Biz Leaders Meet on COVID-19 Vaccine Mandates

WASHINGTON (AP) — President Joe Biden was meeting Wednesday with the CEOs of Walt Disney and Columbia Sportswear, and other... Read More

WASHINGTON (AP) — President Joe Biden was meeting Wednesday with the CEOs of Walt Disney and Columbia Sportswear, and other business executives and leaders leaders to discuss  his recently announced vaccine requirement for companies  that employ at least 100 people.  The White House meeting comes less... Read More

Biden: Nearly 3M Get Health Coverage During COVID-19 Sign-Up

WASHINGTON (AP) — Nearly 3 million consumers took advantage of a special six-month period to sign up for subsidized health... Read More

WASHINGTON (AP) — Nearly 3 million consumers took advantage of a special six-month period to sign up for subsidized health insurance coverage made more affordable by the COVID-19 relief law, President Joe Biden said Wednesday. He called that number encouraging and urged Congress to help keep... Read More

News From The Well
scroll top